The "Victory" Reaction: A Three Component Synthesis of Pyrido[2,3-d]pyrimidines
Poster Jun 27, 2006
Núria Mont, Jordi Teixidó, José I. Borrell, and C. Oliver Kappe
Pedro Victory (1928-1994) spent most of his scientific career studying the synthetic applications of 2-methoxy-6-oxo-1,4,5,6-tetrahydropyridin-3-carbonitriles 3.1 The presence of a methoxy group in pyridones 3 in the ß- position of an a,ß-unsaturated cyano group, which is also conjugated with the lactam NH, render such compoundexcellent substrates for the ethylenic nucleophilic substitution.
This approach allowed us to describe genera lprocedures for the synthesis of pyrazolo[3,4-b]pyridines, 1,6-naphthyridines and 4-aminopyrido[2,3-d]pyrimidinesby treatment of 3 with amidine systems 5. More recently, we described an acyclic strategy for the synthesis of compounds 6 based on the isolation of the corresponding Michael adduct 4 that allowed us to obtain 4-oxopyrido[2,3-d]pyrimidines 6 (R3 = OH).2
Here, we report our preliminary results that pyridopyrimidines 6 can be obtained in a single step as a result of a one-pot three component reaction using controlled microwave-assisted synthesis (Emrys Synthesizer).
The Pathogen Box: A Catalyst for Neglected Disease Drug DiscoveryPoster
Modelled after the Malaria Box, the Pathogen Box contains ~400 diverse drug-like molecules active against neglected diseases of interest such as Chagas disease, cryptosporidiosis, hookworm, sleeping sickness, leishmaniasis, lymphatic filariasis, malaria, onchocerciasis, schistosomiasis, trichuriasis, tuberculosis.READ MORE
Selective Debenzylation of N-Benzyloxypyrazinones in FlowPoster
Selective and reproducible debenzylation of benzyloxypyrazinones by using catalytic transfer hydrogenation in flow chemistry to yield N-hydroxypyrazinones. The flow methodology enabled us to avoid overreduction of the compounds to pyrazin-2(1H)-ones.READ MORE
The Prestwick Chemical Library (R), A Valuable Tool for ScreeningPoster
The Prestwick Chemical Library® (PCL) is Prestwick’s flagship product dedicated to screening. It is a collection of 1280 molecules comprising 100% approved drugs (FDA, EMEA and other agencies) selected for their high chemical and pharmacological diversity. The PCL was designed to reduce the risk of "low quality" hits and therefore the cost of the initial screening, and appears to be an efficient smart library for hit discovery. The PCL comes with an extended fully-annotated database.READ MORE